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Abstract

Francisella tularensis is a gram-negative intracellular bacterium and the etiologic
factor of a potentially fatal disease tularemia. Due to its high infectivity the Centers for
Disease Control and Prevention has designated F. tularensis as a Category A biological
agent.

Nevertheless, the pathogenesis of F. tularensis is not fully understood and

research has failed to develop an effective vaccine.
Production of pro-inflammatory cytokines by innate immune cells at the early
stages of bacterial infection is important for host protection against the pathogen. Many
intracellular bacteria, including F. tularensis, utilize the anti-inflammatory cytokine IL10, to evade the host immune response. It is well established that IL-10 has the ability to
inhibit robust antigen presentation by dendritic cells and macrophages, thus suppressing
the generation of protective immunity.
In the current study, it is hypothesized that F. tularensis polarizes antigen
presenting cells during the early stages of infection towards an anti-inflammatory status
characterized by increased synthesis of IL-10, and decreased production of IL-12p70 and
TNF-α in an IFN-γ-dependent fashion. In addition, F. tularensis drives an alternative
activation of alveolar macrophages within the first 48 hours post-infection, thus allowing
the bacterium to avoid protective immunity.
Furthermore, for the first time, this study demonstrates that targeting inactivated
F. tularensis (iFt) to Fcγ receptors (FcγRs) via intranasal immunization with mAb-iFt
complexes reverses the anti-inflammatory effects of the bacterium on macrophages by

ix

down-regulating production of IL-10 and mediates generation of F. tularensis-specific,
IFN-γ secreting effector memory CD4+ T cells. Furthermore, targeting of iFt to FcγRs
enhances the classical activation of macrophages not only within the respiratory mucosa,
but also, systemically, at the early stages of infection. These results provide important
insight for further understanding the protective immune mechanisms generated when
targeting immunogens to Fcγ receptors validating its potential as a universal vaccine
platform against mucosal pathogens.

x

Introduction

Francisella Tularensis
Tularemia is a zoonotic infection characterized by onset of flu-like symptoms
including fever, chills, headache and enlargement of lymph nodes. The causative agent
of tularemia is Francisella tularensis, a gram-negative facultative intracellular bacterium
that was first described in the literature in 1912 by McCoy and Chapin, as a bacterial
pathogen that caused a plaque-like disease in rodents in Tulare County, California
(McCoy & Chapin, 1912). The bacterium was initially named Bacterium tularensis but
was later re-named Francisella tularensis to honor a researcher Edward Francis, who
extensively studied the pathogen. F. tularensis can be transmitted through insect bites,
infected carcasses, contaminated water, and inhalation of contaminated air, although
inhalation of as little as 1-2 bacteria can lead to respiratory failure and death if left
untreated (Ellis et al., 2002; Metzger et al., 2007; Sjostedt et al., 2007; Oyston et al.,
2008). For this reason, the Centers for Disease Control and Prevention has designated F.
tularensis as a Category A biological agent (Rotz et al., 2002). In fact, The World Health
Organization (1970) predicted that an intentional spread of virulent F. tularensis over a
metropolitan area would lead to 250,000 cases of infection including 19,000 lethal
outcomes.
There are four subspecies of F. tularensis: novicida, holarctica, mediasiatica and
the most virulent subspecies tularensis that has only been found in North America (Cole
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et al., 2011). One of the properties of F. tularensis is its ability to survive and proliferate
within phagocytic cells of the host.

Upon the uptake into the host cell through

phagocytosis, F. tularensis undergoes interaction with early and late endosomes after
which a rupturing of the phagosomal membrane allows bacterium release into a cytosol
(Santic et al., 2005; Chong et al., 2010; Geier et al., 2011). In the cytosol of nonactivated cells the bacteria proliferates rapidly leading to apoptosis of the infected cells
(Sjostedt, 2007). Thus, F. tularensis can evade a critical arm of the innate immune
response by escaping from the phagolysosome pathway of myeloid cells.

Another

mechanism by which F. tularensis alters host cell immunity is increased synthesis of
prostaglandin E2 (PGE2) (Woolard et al., 2007). PGE2 is a potent regulator of the
immune response by skewing it towards an overwhelming Th2 response and subsequent
inhibition of T cell proliferation as opposed to generation of protective Th1 response.
Several studies reported that early innate immune responses, in particular
secretion of inflammatory cytokines such as TNF-α, IFN-γ and IL-12, provide immediate
control over F. tularensis replication (Leiby et al., 1992; Elkins et al., 2003; Duckett et al.
2005). F. tularensis infection, however, is characterized by the absence of early immune
responses throughout the first 2-3 days after infection (Bosio et al., 2007; Rawool et al.,
2008; Singh et al., 2013).

This is believed to occur partly because of the low

endotoxicity of F. tularensis lipopolysaccharide (LPS), which is structurally different
from other Gram-negative bacterial LPS (Ancuta et al., 1996; Barker et al., 2006; Duenas
et al., 2006; Hajjar et al., 2006). One of the differences is the lack of a phosphate at 4'
position on lipid component A, another difference is that F. tularensis lipid A is tetra-
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acylated and contains longer acyl chains of 16 to 18 carbons (Hajjar et al., 2006). These
structural modifications interfere with the binding of LPS to a toll-like receptor 4myeloid differentiation factor 2 (TLR4-MD2) complexes on host pattern recognition
receptors, preventing the TLR4 oligomerization and activation of signaling, therefore,
enabling F. tularensis to better evade the immune response.

Francisella Tularensis Vaccine

Since no licensed vaccine for tularemia is currently available in the United States
and around the world, there is a need for development of an effective vaccine.
Different approaches have been explored to identify routes of protection against
lethal challenge with virulent type of F. tularensis, including whole bacteria and subunit
vaccines. For instance, a vaccine developed by Foshay in 1940’s, consisted of a whole F.
tularensis bacteria killed through acetone extraction followed by phenol preservation.
This vaccine was regarded as a safe formulation and was tested in animal models as well
as administered to a large number of human volunteers. However, the results obtained
from these studies did not show enough efficacies in protection against virulent strains of
F. tularensis (Foshay et al., 1942). Furthermore, studies performed in the former Soviet
Union using live attenuated strain of F. tularensis subspecies holarctica demonstrated
more effectiveness in providing protection against bacterial challenge in comparison to
Foshay vaccine. This vaccine was granted an investigational new drug status by the US
Food and Drug Administration (FDA) and was named Live Vaccine Strain (LVS). Even
though, the use of this vaccine generated quite promising results, the cause of its
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attenuation is still unknown and consequently, LVS has not been approved by FDA for
human administration (Conlan, 2004; Barry et al., 2009; Pechous et al., 2009; Schmitt et
al., 2013). While attenuated in humans, LVS is highly virulent in rodents and therefore,
is widely used in animal models to further understand the pathogenesis of tularemia.
Several studies have also investigated antigenic proteins on the bacterial surface
such as LPS and outer membrane proteins (OMP) to assess their ability to trigger the
protective immune response and to be further utilized for development of subunit
vaccines against F. tularensis infection.

Despite generating a protective antibody

response to challenge with less virulent subspecies of F. tularensis, the subunit vaccines
did not show significant efficacy to challenge with most virulent subspecies of the
bacteria. Given that F. tularensis is an intracellular pathogen, the activation of both
humoral and cell-mediated immunity might be required for stimulation of a sufficient
immune response. Therefore, the search for safe and effective vaccine against infectious
tularemia is still ongoing and various vaccine platforms are currently being evaluated.

Fcγ Receptor Targeting: Overview

Previous studies have shown that targeting antigens to Fc receptors (FcR) on
antigen presenting cells (APCs) leads to enhancement of innate and adaptive immunity
(Gosselin et al., 1992; Rawool et al., 2008; Gosselin et al., 2009; Bitsaktsis et al., 2012;
Iglesias et al., 2012). Fcγ receptors are proteins on the surface of cells such as natural
killer cells, macrophages, dendritic cells, neutrophils and mast cells. There are four
classes of Fcγ receptors currently known in mice: FcγRI, FcγRII, FcγRIII and FcγRIV.
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The first three classes of Fcγ receptors are highly homologous to the human Fcγ
receptors.

Structurally Fcγ receptors have similar extracellular domain, while the

transmembrane and cytoplasmic domains are different (Gessner et al., 1998).
Functionally, the Fcγ receptors differ by their affinities to their ligands and by signaling
they initiate (Ravetch & Kinet, 1991; Nimmerjahn & Ravetch, 2007). The Fcγ receptors
that stimulate cell activation, FcγRI, FcγRIII and FcγRIV, consist of an immunoglobulin
binding α-chain and γ-chain containing signaling motif immunoreceptor tyrosine-based
activation motif (ITAM).

On the other hand, the only inhibitory FcγRIIB receptor

contains α-chain and the immunoreceptor tyrosine-based inhibition motif (ITIM)
(Daeron, 1997; Platzer et al., 2014).

All FcγRs bind with different affinities and

specificities to various subclasses of immunoglobulin G (IgG). Yet, FcγRI is the only
activating receptor that binds to IgGs, in particular IgG1 and IgG3 in humans, and IgG2b
in mice, with significantly higher affinity compared to other FcγRs (Gosselin et al.,
2009). There are four IgG subclasses in humans (IgG1, IgG2, IgG3 and IgG4) and mice
(IgG1, IgG2a, IgG2b and IgG3).
One of the characteristics of the activating Fcγ receptors is their ability to
phagocytose antibody-antigen complexes and further facilitate presentation of processed
antigenic peptides on MHC class I and MHC class II molecules to T cells (Regnault et
al., 1999; Nimmerjahn & Ravetch, 2007). It is believed that these immune complexes
(ICs) bind to Fcγ receptors via Fc region of antibodies leading to cross-linking of the
receptors and subsequent uptake of the ICs. However, Igleasias et al. (2012) observed
that the increase in the FcγR mediated antigen presentation required a physical linkage

5

between the mAb and antigen indicating that receptor cross-linking by itself is not
sufficient for enhanced antigen presentation. The phagocytized antigens are then directed
to the intracellular antigen presentation compartments (Baker et al., 2014; Platzer et al.,
2014). Some studies suggest that the efficient intracellular transport of ICs is mediated
by the neonatal Fc receptor (FcRn), an intracellular receptor expressed within antigen
presenting cells that binds to IgG only under acidic conditions of endocytic vacuoles
(Bitsaktsis et al., 2012; Baker et al., 2014; Guilliams et al., 2014).
It has been previously demonstrated that targeting inactivated F. tularensis (iFt)
bacteria to the FcγRs in mice, via immunization with mAb-iFt immune complexes,
resulted in: (1) enhanced uptake and presentation of the immunogen (iFt) by professional
antigen presenting cells, (2) increased activation and maturation of dendritic cells, (3)
enhanced F. tularensis-specific cytokine and antibody responses, and

(4) increased

protection against F. tularensis infection (Rawool et al., 2008; Iglesias et al., 2012). This
protection was FcγR and FcRn dependent, as immunization of either FcγR or FcRn
deficient mice as well as administration of F(ab’)2 mAb-iFt immune complexes
abrogated protection (Rawool et al,. 2008). In addition, it has been shown that targeting
the pneumococcal surface protein A (PspA) to human FcRI in FcRI transgenic mouse
model, also elicited enhanced protection against Streptococcus pneumoniae challenge
(Bitsaktsis et al., 2012). Therefore, utilization of FcγR targeted approach provides a great
potential for development of an effective vaccine strategy against tularemia.
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Immune responses during F. tularensis infection

For many intracellular bacteria the induction of a robust innate immune response
is a critical factor in host protection and bacterial clearance (Medzhitov & Janeway,
1997; Pashine et al., 2005; Kalinski, 2012).

The induction of innate immunity is

triggered upon recognition of bacterial components such as lipopolysaccharides,
peptidoglycans, or bacterial DNA by cellular receptors in the early phases of infection
and regulated by a number of pro-inflammatory cytokines including IL-12, TNF-α and
IFN-γ and co-stimulatory molecules. Activation of the innate immune system, in turn,
leads to initiation of more complex pathogen-specific adaptive immune responses
responsible for bacterial elimination in the late phases of infection (Alfano & Poli, 2005;
Lacy & Stow, 2011). However, as previously mentioned the F. tularensis infection lacks
the early immune responses throughout the first 2-3 days after infection (Bosio et al.,
2007; Rawool et al., 2008; Singh et al., 2013).
Interleukin-10 (IL-10), an anti-inflammatory cytokine secreted by many different
cell populations including T cells, B cells, macrophages, dendritic cells and keratinocytes
(Shibata et al., 1998; Pestka et al., 2004), inhibits pro-inflammatory cytokine synthesis
and the antigen presenting ability of monocytes/macrophages and dendritic cells
(Asadullah et al., 2003). A number of studies have demonstrated that many intracellular
pathogens, such as F. tularensis, use IL-10 to evade the host immune defense especially
in the initial stages of infection (Abrahamsohn & Coffman, 1996; Salek-Ardakani et al.,
2002; Sing et al., 2002; Metzger et al., 2013).
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The anti-inflammatory cytokine IL-10 is one of the key suppressors of host
immune system that inhibits the antigen presentation ability of macrophages and
dendritic cells mainly by down-regulating the expression of CD80, CD86 and MHC class
II molecules, as well as the production of pro-inflammatory cytokines (Pestka et al.,
2004).

The ability of IL-10 to suppress innate, inflammatory responses against

intracellular pathogens has been previously reported. For instance, lack of endogenous
IL-10 production led to a decrease in number of Trypanosoma cruzi parasites in the blood
of infected mice and increase in production of IFN-γ and nitric oxide (NO), which were
reversed after administration of rIL-10 (Abrahamsohn et al., 1996). Similarly, lack of IL10 resulted in higher resistance of mice to Listeria monocytogenes, characterized by
lower bacterial burden, decreased tissue damage and increased pro-inflammatory
cytokine response (Dai et al., 1997). Furthermore, the V antigen of Yersinia pestis
caused suppression of the Th1 cytokine TNF-α in mouse and human macrophages by
increasing IL-10 synthesis. In the same study, IL-10 deficient mice were highly resistant
to the infection in comparison to wild type (Sing A. et al., 2002). In addition, viruses
have also evolved mechanisms to escape the immune response by altering the Th1/Th2
balance. It has been shown that Epstein-Barr virus (EBV) utilizes the viral IL-10 (vIL10), which is 84% identical in amino acid sequence to the human IL-10, to regulate the
host immune response. Production of vIL-10 by EBV leads to inhibition of IFN-γ
synthesis which is important for early regulation of EBV infection (Salek-Ardakani et al.,
2002). Elevated levels of IL-10 which correlated with higher viral load in HIV infected
individuals were observed by Brockman et al. (2009). However, inhibition of IL-10
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pathway increased synthesis of pro-inflammatory cytokines IFN-γ and IL-2 reversing the
suppression of virus-specific T cell functions that play a key role in controlling HIV
infection (Brockman et al., 2009).
IL-10 has also been identified as a key regulator of immune response to F.
tularensis infection. In particular, IL-10 mediates suppression of IL-17 production in F.
tularensis LVS infected mice (Metzger et al., 2013). IL-17, in turn, is believed to play a
protective role in the initiation of cellular immune response to F. tularensis LVS
infection by induction of IL-12 and IFN-γ production (Lin et al., 2009). Several studies
have demonstrated that blockade of TNF-α, IFN-γ and IL-12 signaling pathways
decreases the survival rate in murine model during F. tularensis LVS infection (Leiby et
al., 1992; Duckett et al., 2005). These cytokines activate production of nitric oxide in
macrophages, which leads to the F.tularensis LVS bacterial killing by causing the
double-stranded DNA breakage, bacterial Fe2+ release and depletion of antioxidant
glutathione (Chakravortty et al., 2003; Lindgren et al., 2005).
F. tularensis predominantly infects antigen presenting cells such as macrophages
and dendritic cells, the primary components of host defense mechanism. Therefore,
activation of these cells plays an important role in controlling the replication of F.
tularensis.

Depending on the extracellular cytokine background, the activated

macrophages are divided into two distinct groups, classically activated macrophages
(AM1) associated with high levels of pro-inflammatory cytokines and alternatively
activated macrophages (AM2) characterized by increased levels of anti-inflammatory
cytokines, in particular IL-10 (Benoit et al., 2008). In addition to a distinct cytokine and
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chemokine milieu, polarized macrophages portray different receptor expression (Mosser,
2003; Mantovani et al., 2004; Badylak et al., 2008; Benoit et al., 2008; Tomioka et al.,
2012; Jaguin et al., 2013). Thus, CCR7, B7.1 (CD80), B7.2 (CD86) and MHCII have
been identified as reliable surface markers that are up-regulated in classically activated
macrophages. On the other hand, numerous studies have reported up-regulation of FIZZ1 and Arg-1 in alternatively activated macrophages during infection, cancer and
inflammatory conditions such as atherosclerosis (Raes et al., 2002; Benoit et al., 2008;
Meghari et al., 2008; Ishii et al., 2009;

Porta et al., 2009; Sanson et al., 2013).

Classically activated macrophages are critical in control of replication of intracellular
bacteria and therefore, required for host’s defense against various infections (Katakura et
al., 2004; Benoit et al., 2008; Shaughnessy et al., 2010). It has been previously proposed
that one of the mechanisms that F. tularensis utilizes to subdue the protective immune
response is its ability to induce the activation of alternatively activated macrophages to
inhibit the protective M1 activation (Shirey et al., 2008).

Generation of Memory T cells

One of the main goals of vaccine strategy is the induction of a long-lasting
protective memory. The properly activated antigen presenting cells play an important role
in activation of pathogen-specific adaptive immunity (Beverley, 2002). The generation
of a T-cell memory, in particular, is essential to long lasting protective immunity which
consists of T helper lymphocytes or CD4+ and killer T lymphocytes or CD8+.

In

addition, there are two types of T memory cells, effector memory (TEM) and central

10

memory (TCM) cells that differ based on their functional responses as well as the
expression of CD62L and CCR7 cell surface markers. Specifically, TCM cells migrate to
lymphoid tissues where they stimulate dendritic cells and induce a new generation of the
effector T cells. On the other hand, TEM cells are located largely in peripheral tissues
where they activate a protective immune response against infectious pathogens including
elevated production of inflammatory cytokines such as IFN-γ. Furthermore, TCM cells
express adhesion molecule CD62L and chemokine receptor CCR7 that are critical for T
cell migration to lymph nodes, while TEM cells are negative for both receptors (Gunn et
al., 1998; Sallusto et al., 1999; Campbell & Butcher, 2000; Esser et al., 2003; McKinstry
et al., 2010).
Polarization of T cells, regulated by antigen presenting cells via interaction with
T cell receptor, is an important attribute of immune responses. There are three main
subtypes of CD4+ T cells that differ based on the secreted cytokine milieu – Th type 1
(Th-1), Th type 2 (Th-2) and Th type 17 (Th-17) cells (Sattler et al., 2009). Th-1 cells
secrete pro-inflammatory cytokines such as IFN-γ and TNF-β that provide an effective
cell-mediated response against intracellular pathogens.

Th-2 cells secrete anti-

inflammatory cytokines including IL-4 and IL-10 that trigger antibody-mediated
response. Finally, Th-17 cells secrete cytokines such as IL-17, IL-17F and IL-22 that
contribute to generation of protection against extracellular pathogens (Esser et al., 2002;
Kaiko et al., 2007).

T cell polarization largely depends on cytokines released by

activated APCs and is triggered upon binding of these cytokines to their respective
receptors on the surface of T cells. For instance, it has been previously shown that IL-12,
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a heterodimeric cytokine produced by APCs in response to intracellular pathogens, is
required for development of IFN-γ producing Th-1 cells. Moreover, the two cytokines
act in an autocrine manner amplifying the Th-1 polarization and subsequently enhancing
generation of an immune response (Macatonia et al., 1995; Schroder et al., 2004).
Although cell mediated responses are critical to generation of long term immunity against
intracellular infection, it has been shown previously that F. tularensis skews the T cell
response from pro-inflammatory Th-1 towards anti-inflammatory Th-2 response, leading
to inhibition of T cell activation (Woolard et al., 2007). Therefore, further understanding
of the mechanisms utilized by F. tularensis to evade host immune responses will help for
development of an effective vaccine against tularemia.
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Aims of the study

1. To characterize the inflammatory responses in mice during early phase of F.
tularensis infection
In the current study we hypothesized that F. tularensis polarizes antigen
presenting cells (APCs) during the first 48 hours post-infection towards an antiinflammatory status, characterized by IL-10 production, thus allowing the pathogen to
avoid protective anti-bacterial innate immune responses.
2. To characterize the immune responses in mice upon delivery of immune
complexes to Fcγ receptors during early phase of F. tularensis infection
We seek to determine whether targeting of mAb-iFt immune complexes to FcγRs
reverses the potential detrimental role of IL-10 during the early stages of Francisella
infection.
3. To characterize the effect of Fcγ targeted mucosal vaccination on dendritic cell
activation and memory CD4+ T cell formation in vivo during lethal challenge
with F. tularensis LVS
It has been previously shown that targeting immune complexes to Fcγ receptors
stimulates dendritic cell activation and maturation leading to enhanced iFt presentation to
T cells in vitro (Iglesias et al. 2012). Nevertheless, questions remain regarding the in vivo
impact of mAb-iFt immunization and whether DC activation and T cell priming also
occur in vivo when utilizing the FcγR targeted vaccine strategy.
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Materials and Methods

Mice and bacteria:
C57BL/6, IL-10 genetically deficient and IL-12p35 genetically deficient mice
were purchased from Jackson Laboratories (Bar Harbor, Maine). All mice were housed
at the Animal Research Facility at Seton Hall University. The mice were used at 6-10
weeks of age. All protocols were reviewed and approved by the Seton Hall University
Ethics Committee utilizing NIH standards. Mouse anesthesia was performed via i.p.
injections of a ketamine/xylazine cocktail, while mouse euthanasia was achieved via CO2
administration followed by cervical dislocation.
F. tularensis LVS (ATCC 29684; American Type Culture Collection) was
provided by K. Elkins (U.S. Food and Drug Administration, Bethesda, MD).

Antibodies:
Mouse IgG2a anti-Ft. LPS mAb used to generate mAb-iFt immune complexes
was purchased from Fitzgerald (Cat# 10-F02, clone#M023621, Acton, MA).

The

following flow cytometry antibodies were purchased from BD Biosciences (San Jose,
California): F4/80 (PE), anti-CD3 (FITC), anti-CD4 (APC), anti-CD44 (PE), anti-CD62L
(PercP Cy 5.5), anti-CD11b (FITC), anti-CD11c (APC), anti-IFNγ (PE), anti-DEC-205
(PercP Cy 5.5), anti-CCR7 (PE-Cy7), anti-CCR7 (PE-Cy5.5), MHC class II (APC), B7.1
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and B7.2 (PercP). For neutralizing IL-12p35 in vivo, the rat IgG2a anti-mIL12 (clone:
C18.2) and its isotype control were purchased from eBioscience (San Diego, CA).

Inactivation and Labeling of F. tularensis:
Inactivated F. tularensis LVS (iFt) was generated by growing F. tularensis LVS
in Mueller Hinton broth (MHB) media (BD Biosciences) up to a density of 1x109
CFU/mL. The culture was then spun down at 22,000g for 20 minutes at 4oC, and washed
3 times with PBS, resuspended in 2% Paraformaldehyde (PFA) (Sigma) and incubated
for 2 hours at room temperature on a rocker. Bacteria were then washed 3 more times
with PBS and 1x109 organisms were plated on a chocolate agar plate (BD Biosciences)
and incubated for 7 days at 37°C to confirm inactivation. The final concentration of iFt
organisms was determined by OD at 610 nm.

mAb-iFt Immune Complex (IC) Generation:
To generate ICs, 1x109 iFt organisms were incubated at 4°C overnight on a rocker
with 0 µg/mL or 1µg/mL of mAb-iFt or anti-iFt F(ab’)2 in PBS. Following incubation,
iFt, mAb-iFt or F(ab’)2-iFt preparations were washed once with PBS to remove any
unbound antibody and administered to mice intranasally. Generation of ICs has been
previously confirmed by ELISA and SDS-PAGE (Rawool et al., 2008; Iglesias et al.,
2012).
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Immunization and Challenge Studies:
C57BL/6, IL-10 deficient and IL-12p35 deficient mice were divided into three
groups consisting of 5-6 mice/group, 6-10 weeks or 8-12 weeks of age. Each mouse was
immunized on days 0 and 21 with 2x107 iFt organisms alone or in the form of mAb plus
iFt ICs. On day 35 the mice were challenged with 10,000 CFU of live F. tularensis LVS.
Following challenge survival was monitored twice-daily for 21-25 days. Death, due to
the infection, was considered as the experimental end-point, although, in the occasions
were animals deemed to suffer (i.e. completely immobile, hunched backs, eyes shut),
mice were sacrificed via CO2 administration followed by cervical dislocation, per our
approved animal protocol (Approval # CB1401). Exact CFU administered were also
verified by culturing and counting the inoculum subsequent to challenge on chocolate
agar plate.

Lung leukocyte isolation:
Lungs of immunized mice were harvested 24, 48 and 96 hours post-infection,
perfused with cold 1x PBS containing a protease inhibitor cocktail, shredded into small
pieces, and placed in digestion buffer containing RPMI (Life Technologies), 0.2mg/mL
DNaseI (Sigma), 0.4mg/mL Collagenase D (Sigma), and 1M MgCl2. After a 30 minute
incubation at 37oC the digested tissue samples were forced through a cell strainer and the
cell suspension obtained was washed and resuspended in RPMI containing 2% FBS. The
cell suspension was then carefully layered on 5 mLs of Lympholyte M (Cedarlane
Laboratories, Burlington, NC), and spun down at 15,000g for 30 minutes at room
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temperature. Following centrifugation, the interface containing the majority of immune
cells was obtained and added in RPMI with 2% FBS prior to enumeration. Identification
and enumeration of alveolar macrophages was based on the expression of surface
antigens F4/80 and CD11b. In case of DCs isolation, lung leukocytes were cultured in
petri dishes containing complete medium at 2x106 cells/mL for 1 hour at 37°C.
Identification and enumeration of DCs was based on the expression of CD11c and DEC205. These markers are primarily expressed on mouse DCs (Kronin et al., 2000; Bonifaz
et al., 2004). Nevertheless, a small percentage of alveolar macrophages (3-4%) are also
positive for these markers (Higgins et al., 2008). Therefore, in order to further increase
DC purity, lung white blood cells were cultured for 30 minutes at 37°C in petri dishes to
remove (via adherence) the lung macrophages.

Peritoneal exudate cell (PEC) isolation:
PECs were harvested 48 hours post-infection, centrifuged in a refrigerated
centrifuge 4,000g for 10 minutes. Following centrifugation, the interface containing
PECs was resuspended in RPMI with 10% FBS, prior to enumeration. Identification and
enumeration of PECs was based on the expression of surface antigens F4/80.

Neutralization of IL-12 in vivo:
Two doses of rat anti-murine anti-IL-12p35 mAb (C18.2) were administered
intraperitoneally (i.p.) (500μg in 250μl of PBS) on days -1, 0 and 1 post-LVS infection.
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This method has been proven to neutralize IL-12 in vivo for a minimum of five days postadministration of the IL-12p35 mAb (Meyts et al., 2006).
Flow cytometry:
Peritoneal exudate cells, lung parenchymal cells or splenocytes were obtained
from immunized mice at different time-points post-F. tularensis LVS infection as
described above. For cell surface marker staining, cells were washed with PBS-BSAazide, resuspended in blocking buffer [PBS-BSA-azide plus 30 µg/mL of normal mouse
IgG (Sigma)] and incubated on ice for 30 minutes. Cells were then washed with PBSBSA-azide and fluorescently labeled antibodies to CD11b, CD11c, F4/80, DEC-205,
MHC class II, B7.1, B7.2, CCR7, CD3, CD4, CD44, CD62L or their corresponding
isotype controls were added. The cells were then incubated on ice for 30 minutes,
washed, and then fixed with 2% paraformaldehyde (PFA). Cells were then analyzed by
flow cytometry on an LSRII flow cytometer (BD Biosciences).

Intracellular cytokine staining:
Splenocytes (SPCs) from immunized mice were obtained 2 days post-LVS
infection and cultured for 5 hours at 37oC in the absence or presence of LVS (1x103
CFUs per 2x105 SPCs). For a positive control, SPCs were cultured in complete media
(RPMI, 2% FBS, L-glutamine), with 50ng/mL PMA (Sigma) and 500ng/mL ionomycin
(Sigma).

Cell media also contained protein transport inhibitor with 10 μg/mL of

Brefeldin A (GolgiPlug – BD Biosciences). Following incubation, the cells were washed
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with PBS-BSA-azide (containing the protein transport inhibitor), resuspended in blocking
buffer, and stained with the cell surface marker antibodies for CD3, CD4, and CD44, and
fixed with 2% PFA as described above.
After fixation, cells were washed, resuspended, and incubated in permeabilization
buffer (BD Biosciences) for 15 minutes at 4oC to facilitate pore formation. Anti-mIFN-
was diluted in permeabilization buffer and added to each cell sample. Cells were further
incubated on ice for 30 minutes. Following incubation, cells were washed, resuspended
in PBS-BSA-azide, and analyzed by flow cytometry on an LSRII flow cytometer (BD
Biosciences).

For intracellular cytokine staining of lung DCs, the latter cells were

obtained from immunized mice, as previously described, 2 days post-LVS challenge.
DCs were stained for the cell surface markers: DEC-205 and CD11, and intracellularly
for IL-12, as described above. The results were analyzed by flow cytometry on an LSRII
flow cytometer (BD Biosciences).

Cytokine measurements:
C57BL/6 mice were immunized intranasally (i.n) with PBS, iFt (1x109 CFUs), or
mAb-iFt, boosted on day 21 and challenged on day 35 with either 10,000 CFUs or 20,000
CFUs of F. tularensis LVS. After 48 hours post-infection peritoneal cells or lung DCs
were obtained from all groups and cultured for 24 or 48 hours with either F. tularensis
LVS (1:10 and 1:100 MOI or 1x103 CFUs/well), F.tularensis LPS (kindly provided by
Dr. Timothy Sellati – Albany Medical College, Albany, NY) or E. coli-LPS (Sigma) at 1
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ng/mL, 10 ng/mL and 20 ng/ml, or recombinant IFN-γ (Invitrogen) at 100 U/mL.
Supernatants were collected at designated time points and the levels of IL-12p70, TNF-α
and IL-10 cytokines were measured using BD Biosciences Cytometric Bead Array
(CBA) following vendor instructions.
In a separate experiment, lung tissue (left lobe) was harvested from immunized
mice and homogenized (Omni Homogenizer, Omni International, GA). Homogenates
were then spun down at 15,000g for 30 minutes at room temperature to remove tissue
debris and cytokine levels were detected by using the IL-6, IL-10, TNF-α and IFN-γ
ELISA kits by following vendor instructions (Biolegend).

Statistical Analysis:
The Log-Rank (Mantel-Cox) test was used for survival curves.

Statistical

differences among the groups were analyzed using a one-way analysis of variance
(ANOVA) or the unpaired, one-tailed student t-test. GraphPad Prism 4 provided the
software for the statistical analysis (San Diego, CA).
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Results

Administration of mAb-iFt immune complexes (ICs) reverses the anti-inflammatory
properties of F. tularensis LVS ex vivo and increases the activation of mouse
peritoneal exudate cells (PECs)
One of the critical immune responses to bacterial infection is the synthesis and
release of pro-inflammatory cytokines by innate immune cells during the early stages of
infection (Medzhitov & Janeway, 1997; Pashine et al., 2005; Kalinski, 2012). Given the
ability of F. tularensis to evade the immune system by favoring the short-term secretion
of anti-inflammatory cytokines (Bosio, 2011; Metzger et al., 2013), it was of interest to
investigate the cytokine levels produced by PECs at the early stages of infection.
Therefore, production levels of inflammatory cytokines IL-12p70 and TNF-α as well as
the anti-inflammatory cytokine IL-10 were analyzed using PECs from immunized and
subsequently challenged mice. On day 35 post-immunization mice were challenged with
10,000 CFU of live F. tularensis LVS and cells were isolated two days post-infection.
PECs were further stimulated with F. tularensis LVS ex vivo (at 1:10 and 1:100 MOI) for
24 hours and the cytokine levels in the supernatant were measured by the BD Biosciences
Cytometric Bead Array (CBA). The levels of IL-12p70 (Fig.1A) and TNF-α (Fig. 1B) in
supernatants from PECs of mAb-iFt immunized mice were significantly higher (two to
three fold) in comparison to mice immunized with iFt alone. By contrast, the levels of
IL-10 production were 2-fold lower in the mAb-iFt compared to mice immunized with
iFt alone (Fig. 1C) independent of the MOI tested.
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Fig.1 Administration of mAb-iFt immune complexes reverses the anti-inflammatory
properties of LVS in mouse PECs ex vivo
7
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10 CFUs), or
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of Ft LVS.
After 48 hours after F. tularensis LVS challenge, the PECs of immunized mice were
harvested and cultured in the presence or absence of F. tularensis LVS at 1:10 and 1:100
MOI for 24 hrs. The cytokine production was measured as previously described. Results
shown are mean ± SD from three independent experiments determined by one-way
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05).
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IL-10 is known to decrease the cell surface expression of MHC class II and costimulatory molecules CD80 and CD86 on murine macrophages (Ding et al., 1993).
However, one of the mechanisms by which immune complexes trigger immune responses
is via T cell activation that requires robust antigen presentation by activated antigen
presenting cells and increased expression of co-stimulatory molecules.

Previous

experiments have shown that co-culturing of F.tularensis- specific T cell hybridoma with
mouse PECs in the presence of mAb-iFt noticeably increased F.tularensis-specific T cell
responses compared to using the iFt immunogen alone (Iglesias et al., 2012). Therefore,
the hypothesis was that targeting of immunogen to Fcγ receptors (FcγRs) increases
systemically the activation status of antigen presenting cells following F. tularensis LVS
challenge. Thus, the expression of MHC class II and co-stimulatory molecules CD80 and
CD86 were measured on PECs from immunized mice post-infection.
Peritoneal cells were obtained from immunized mice two days after F. tularensis
LVS challenge as described in Materials and Methods, and the expression of the murine
macrophage cell-surface marker F4/80, the co-stimulatory molecules CD80 and CD86, as
well as MHC class II was determined by flow cytometry. Although the number of cells
expressing the F4/80 cell surface marker was similar between the iFt and mAb-iFt
immunized mice, the number and frequency of cells expressing both MHC class II and
CD80/CD86 molecules was significantly increased in the mAb-iFt group (Fig. 2). This
enhancement in surface marker expression upon immunization with mAb-iFt correlates
with the increased presentation of iFt in the presence of mAb-iFt in vitro (Iglesias et al.,
2012).
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Fig. 2: Immunization with mAb-iFt immune complexes increases the activation of
PECs following LVS challenge
7
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10 CFUs), or
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of iFt LVS. On
day 2 post-infection the peritoneal exudate cells of immunized mice were harvested and
the expression of F4/80, MHC class II, B7.1 (CD80), and B7.2 (CD86) were analyzed by
flow cytometry. Results shown are mean ± SD from three independent experiments
determined by one-way ANOVA and Student’s t-test (* P-value ˂ 0.1; ** P-value ˂ 0.05).
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These results demonstrate for the first time that intranasal immunization with
mAb-iFt favors a pro-inflammatory cytokine profile secreted by murine macrophages as
depicted by an increase of IL-12p70 and TNF-α production and inhibition of IL-10.
Moreover, it triggers activation of peritoneal macrophages during F. tularensis infection,
indicating the induction of a systemic response in vivo.

F. tularensis LPS contributes to the anti-inflammatory properties of F. tularensis
LVS in an IFN-γ and IL-10 dependent manner
It is well established that F. tularensis LPS is structurally different from other
intracellular bacteria and elicits a subdued inflammatory response in the initial stages of
infection, which otherwise are critical in controlling bacterial burden (Ancuta et al., 1996;
Barker et al., 2006; Duenas et al., 2006; Hajjar et al., 2006). To investigate the effect F.
tularensis LPS on the cytokine profile produced by PECs, the levels of IL-12p70, TNF-α
and IL-10 were measured in the supernatants of PECs from naïve C57BL/6 mice cultured
with various concentrations of F. tularensis LPS.

As expected, incubation with F.

tularensis LPS at different concentrations triggered significantly lower levels of IL-12p70
(Fig. 3A) and TNF-α (Fig. 3B) secretion compared to E. coli LPS (positive control). In
contrast, IL-10 production was elevated in the presence of F.tularensis LPS (Fig. 3C).
This observation not only confirms the low endotoxic activity of F. tularensis LPS but
also indicates that it down-regulates Th-1 cell mediated inflammatory responses via upregulation of IL-10 and down-regulation of IL-12p70 and TNF-α.
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Fig. 3 F. tularensis LPS contributes to the anti-inflammatory properties of F.
tularensis LVS during the early stages of infection
PECs from C57BL/6 mice (n=5 for each group) were obtained and cultured in a 96-well
5
plate at 2 x 10 cells/well in the presence or absence of either Ft-LPS or E. coli-LPS at 1
ng/mL, 10 ng/mL and 20 ng/ml. Cells incubated with PBS were used as a control. Levels
of IL-12p70, TNF-α and IL-10 were measured using BD Biosciences Cytometric Bead
Array (CBA) following vendor instructions. Results shown are mean ± SD from three
independent experiments determined by one-way ANOVA (* P-value ˂ 0.1; ** P-value ˂
0.05).
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Several studies have shown that IL-10 negatively regulates synthesis of IFN-γ as
well as synthesis of other pro-inflammatory cytokines in monocytes and macrophages
(Donnelly et al., 1995; Brustoski et al., 2005; Cope et al., 2011). Due to the increased
levels of IL-10 synthesis after incubation of PECs with F. tularensis LPS it was of
interest to examine whether this up-regulation correlates with the decrease in TNF-α and
IL-12p70 secretion.

To investigate this, PECs from C57BL/6 wild-type and IL-10

genetically deficient mice were incubated with F. tularensis LPS or E. coli LPS. As
previously observed, in the absence of endogenous IFN-γ, F. tularensis LPS portrayed
anti-inflammatory properties via up-regulation of IL-10 production and decrease in the
synthesis of IL-12p70 and TNF-α by the PECs. Interestingly, these results were reversed
by the addition of exogenous IFN-γ (Fig. 4A-4C). Lack of endogenous IL-10, in turn,
resulted in an elevated synthesis of IL-12p70 (Fig.4D) and TNF-α (Fig. 4E). These
results indicate that increased levels of IL-10 synthesis is one of the mechanisms
responsible for suppressing the protective pro-inflammatory cytokines such as TNF-α and
IL-12p70 leading to an overall suppression of the Th-1 response and reduced IFN-γ
levels in the early stages of F. tularensis infection. In fact, the importance of IFN-γ
during F. tularensis infection was reported by Rawool and colleagues (Rawool et al.,
2008), who observed a significant drop in survival rate in the mAb-iFt immunized IFN-γ/-

mice compared to the wild type control.
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Fig. 4 Anti-inflammatory effect of F. tularensis LPS on mouse PECs is IFN-γ and
IL-10 dependent
PECs from naïve and IL-10 genetically deficient C57BL/6 mice (n=5 for each group)
were obtained and resuspended in cell culture media. PECs were cultured in a 96-well
plate at 2 x 105 cells/well with either Ft-LPS or E. coli-LPS at 1 ng/mL in the presence or
absence of recombinant IFN-γ at 100 U/ml. Cells cultured with PBS were used as a
control. The cytokine production was measured using BD Biosciences Cytometric Bead
Array (CBA) following vendor instructions. Results shown are mean ± SD from three
independent experiments determined by one-way ANOVA and Student’s t-test (* P-value
˂ 0.1; ** P-value ˂ 0.05).
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Administration of mAb-iFt immune complexes reverses the anti-inflammatory
properties of F. tularensis LVS in the lungs of immunized mice
The balance and kinetics of pro- and anti-inflammatory cytokine secretion during
F. tularensis challenge are key players in controlling the outcome of infection (Bosio et
al., 2007; Mares et al., 2008; Sharma et al., 2009). Consequently, having shown that
immunization of mice with mAb-iFt favors a pro-inflammatory cytokine profile secreted
by PECs in vitro, the attempt was to determine the effect of our FcγR targeting approach
on the levels of inflammatory cytokines in the lungs of immunized mice during the early
stages of F. tularensis LVS infection.

To accomplish this, C57BL/6 mice were

immunized with PBS, or iFt, or mAb-iFt, boosted on day 21 and infected with a lethal
dose of F. tularensis LVS on day 35 post-immunization. The lungs of euthanized mice
were harvested after 24, 48 and 96 hours post-challenge, homogenized, and the IL-6, IL10, TNF-α and IFN-γ cytokine levels were measured by direct sandwich ELISAs. The
obtained results indicate a faster pro-inflammatory response in the lungs of mAb-iFt
immunized mice compared to mice immunized with iFt alone, as assessed by the IL-6
and TNF-α production kinetics. Levels of IL-6 and TNF-α peaked at 48 hours postinfection, while they were significantly decreased by day 4 post-challenge (Fig. 5). This
observation was accompanied by a drop of the bacterial load (data not shown). On the
other hand, the pro-inflammatory cytokine levels tested continued to increase at 96 hours
post infection in both the PBS and iFt immunized mice accompanied by an increase in
the bacterial burden in the lungs (Fig. 5 and data not shown). Similar results among the
three groups of mice were noted with IFN-γ (Fig. 5). On the contrary, the levels of IL-10
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were significantly higher in mice immunized with either iFt or PBS versus mAb-iFt
within the first 24 of infection, indicating the early anti-inflammatory properties of F.
tularensis LVS. Importantly, the decrease of IL-10 in the mAb-iFt immunized mice
observed at 96 hours post-infection was consistent with the previous observation,
indicating that FcγR targeting shifts towards a pro-inflammatory cytokine profile at the
early stages of F. tularensis infection (Fig. 2 and Fig. 5).
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Fig. 5: Administration of mAb-iFt immune complexes reverses the antiinflammatory properties of LVS in the lungs of immunized mice
7
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (2x10 CFUs), or
mAb-iFt, boosted on day 21 and challenged on day 35 with 10,000 CFUs of F.tularensis
LVS. Lung tissue homogenates were obtained from immunized mice 24, 48 and 96 hours
post-infection as indicated above and spun down at 15,000g for 30 minutes at room
temperature to remove tissue debris. Cytokine levels were detected by using the IL-6, IL10, TNF-α and IFN-γ ELISA kits and following vendor instructions (Biolegend). Results
shown are mean ± SD from three independent experiments determined by one-way
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05).
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FcγR targeting drives polarization of mouse macrophages towards the AM1
phenotype at the early stages of F. tularensis LVS infection
The results of these experiments have suggested so far that one of the immune
evasion mechanisms exploited by F. tularensis is the reduction of pro-inflammatory
cytokines during the early stages of infection.

To further investigate possible

mechanisms responsible for this shift in the innate immune response, the effect of FcγR
targeting on macrophage activation and phenotype was analyzed in the lungs of
immunized mice. Previous research showed that one of the ways of F. tularensis survival
and replication within the host cell is its ability to alter the macrophage activation from
classically activated alveolar macrophages (AM1) to alternatively activated alveolar
macrophages (AM2) (Shirey et al., 2008). The AM1 macrophages are characterized by
high levels of pro-inflammatory cytokines and thus, play an essential role in anti-bacterial
innate immune response. In contrast, AM2 macrophages are associated with high levels
of anti-inflammatory cytokines, in particular IL-10 (Katakura et al., 2004; Tomioka et al.,
2012). Therefore, the flow cytometric analysis was performed to assess the number of
AM1 and AM2 present upon immunization with mAb-iFt.

C57BL/6 mice were

immunized with PBS, iFt, or mAb-iFt, boosted on day 21 and infected with a lethal dose
of F. tularensis LVS on day 35 post-immunization. The lungs of euthanized mice were
harvested 24, 48 and 96 hours post-challenge and the levels of F4/80, CD11b, CCR7,
MHC class II and B7.2 marker expression on white blood cells was analyzed by flow
cytometry.

Classically

activated

AM1

cells

are

characterized

as

F4/80+/CD11bint/CCR7+/MHC classII+/B7.2+ cells, while AM2 cells were identified as
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F4/80+/CD11bint/CCR7-/ MHC classII-/B7.2- (Mantovani et al., 2004; Tomioka et al.,
2012). The frequency and number of AM1 cells was significantly higher in mAb-iFt
immunized group of mice compared to mice immunized with iFt alone, especially at the
early stages of F. tularensis LVS infection 24 and 48 hours post challenge (Fig. 6).
Interestingly, the levels of AM1 cells were comparable among the different immunized
groups at 96 hours of post challenge. In addition, the data showed a significantly lower
number of AM2 cells in the lungs of mAb-iFt immunized mice relative to mice
immunized with iFt alone at all three time points post-infection. It is also of interest that
mice immunized with PBS had the highest frequency of AM2 cells, proposing that AM2
polarization in vivo may be an additional immune evasion strategy of F. tularensis,
especially at the early stages of infection.
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Fig. 6 FcγR targeting drives polarization of mouse macrophages towards the AM1
phenotype at the early stages of LVS infection
Lungs of immunized mice (n=6 for each group) were harvested 24, 48 and 96 hours postinfection. For cell surface marker staining, cells were washed with PBS-BSA-azide,
resuspended in blocking buffer [PBS-BSA-azide plus 30 µg/ml of normal mouse IgG
(Sigma)] and incubated on ice for 30 minutes. Cells were then washed with PBS-BSAazide and fluorescently labeled antibodies to CD11b, F4/80, MHC class II, B7.1, B7.2,
CCR7, or their corresponding isotype controls were added. The cells were then incubated
on ice for 30 minutes, washed, and then fixed with 2% paraformaldehyde. Cells were
then analyzed by flow cytometry on an LSRII flow cytometer (BD Biosciences). Results
shown are mean ± SD from three independent experiments determined by one-way
ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05).
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Enhanced maturation and activation of DCs in the lungs of mice immunized
intranasally with mAb-iFt ICs
It has been previously demonstrated that targeting iFt to FcγRs via the intranasal
administration of pre-formed mAb-iFt ICs elicits protective responses against lethal
challenges with F. tularensis LVS, and the category A F. tularensis agent, SchuS4
(Rawool et al., 2008; Czerkinsky et al., 2012). The protection observed was based on
survival studies, bacterial burdens, and immunohistochemical analysis of mouse tissues.
The protective effect was due to targeting of bacterial antigens to FcγR through
opsonization with an anti-LPS IgG2a mAb. The antibody alone had no protective effect
on mice against F. tularensis challenge. Furthermore, it was shown that targeting iFt to
FcRs on APCs mediates internalization, processing, and presentation of the immunogen
to F. tularensis-specific T-cell hybridoma in vitro (Rawool et al., 2008, Iglesias et al.,
2012).

Since DCs play a key role in processing and presenting antigens to T

lymphocytes, effectively bridging the innate and adaptive immune system, experiments
were designed to focus on the effect immunization with mAb-iFt ICs has on the number
of activated DCs in the lungs of immunized mice. For this purpose, C57BL/6 mice were
immunized with PBS, iFt, F(ab’)2-iFt or mAb-iFt and boosted on day 21. On day 35
post-immunization, lungs were harvested, digested, and the DCs were purified using
lympholyte, followed by a one hour incubation at 37oC on petri dishes to negatively
select for the adherent cells, such as macrophages. Following selection, we used the
expression of CD11c and DEC-205 markers to define lung DCs ( Witmer-Pack et al.,
1995; Kronin et al., 2000; Bonifaz et al., 2004). All the selected cells that were CD11c+
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were also positive for the dectin marker (DEC-205), indicating the DC purity of more
than 98% (data not shown). The activation status of lung DCs was based upon the
expression of MHC class II, B7.1, and B7.2 and the analysis was performed by flow
cytometry. Interestingly, no significant differences were noted among the three groups of
immunized mice (data not shown). In contrast, when immunized mice were infected with
a lethal dose of F. tularensis LVS on day 35 post-immunization, and their DC profile was
analyzed at different time points post-infection, there was a significant difference in the
frequency and activation status of lung DCs between the iFt and mAb-iFt groups. More
specifically, on days 2 and 5 post-infection there was a significantly higher number of
CD11c+/DEC-205+ cells in the lungs of mAb-iFt immunized mice compared to mice
immunized with iFt alone or F(ab’)2-iFt (Fig. 7B and 7C), potentially indicating
increased recruitment of DCs in the lungs during infection. This difference was not
significant on day 7 (Fig. 7D). It is also interesting to note that the overall white blood
cell (WBC) cellularity in the lungs of mAb-iFt immunized mice was significantly
increased following F. tularensis LVS challenge (Fig. 7A).
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Fig. 7 Immunization of mice with mAb-iFt immune complexes enhances the number
of CD11c+ cells in the lungs of immunized mice following F. tularensis LVS challenge
9
C57BL/6 mice (n=6 for each group) were immunized i.n. with PBS, iFt (1x10 CFUs),
F(ab’)2-iFt or mAb-iFt, boosted on day 21 and challenged on day 35 with 20,000 CFUs
of F.tularensis LVS. On days 2, 5, and 7 post-infection the lungs of immunized mice were
harvested and the white blood cells were obtained and counted (A). Lungs were also
harvested from unimmunized and uninfected mice (naïve) as a baseline control. The
frequency of CD11c+/DEC-205+ cells was measured by flow cytometry and translated
into absolute numbers for days 2 (B), 5 (C), and 7 (D) post-infection. Naïve mice were
neither immunized nor challenged. Results shown are mean ± SD from three independent
experiments determined by one-way ANOVA and Student’s t-test (* P-value ˂ 0.1; ** Pvalue ˂ 0.05). There was no significant difference between the two groups on day 7 post
LVS infection.
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On a similar note, the expression (Fig. 8) and absolute numbers (Fig. 9) of
CD11c+ cells expressing MHC class II, B7.1, and B7.2 were significantly higher in the
mAb-iFt immunized group compared to the group immunized with iFt alone or F(ab’)2iFt, indicating for the first time that mucosal targeting of an immunogen to FcR does not
only enhance the frequency of DCs in the lungs upon subsequent infection, but also
mediates in vivo DC maturation and activation enabling them to become better antigen
presenting cells.
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Fig. 8 Increased frequency of activated CD11c+ dendritic cells in the lungs of mice
immunized with mAb-iFt immune complexes and challenged with F. tularensis LVS
C57BL/6 mice (n=3 for each group) were immunized i.n. with PBS, iFt (1x109 CFUs),
F(ab’)2-iFt or mAb-iFt, boosted on day 21, and challenged on day 35 with 20,000 CFUs
of iFt LVS. On day 2 post- LVS infection the lungs of immunized mice were harvested
and the white blood cells were stained and analyzed by flow cytometry to obtain the
expression levels of MHC class II (A), B7.1 (B), and B7.2 (C) on lung dendritic cells
(CD11c+/DEC-205+). Results shown are representative of three independent experiments.
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Fig. 9 Immunization of mice with mAb- iFt immune complexes increases the
number of activated CD11c+ lung dendritic cells following F. tularensis LVS
challenge
C57BL/6 mice (n=6 for each group) were immunized and challenged as in Fig. 8. On
days 2 and 5 post- F. tularensis LVS infection the lungs of immunized mice were
harvested and the white blood cells were obtained and counted. The frequencies of
CD11c+/DEC-205+/MHC class II+ (A), CD11c+/DEC-205+/B7.1+ (B), and CD11c+/DEC205+/B7.2+ (C) were translated into absolute cell numbers. Results shown are mean ± SD
from three independent experiments determined by one-way ANOVA (* P-value ˂ 0.1;
** P-value ˂ 0.05).
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Immunization with mAb-iFt ICs enhances the generation of effector memory CD4+
T cells during F. tularensis LVS challenge
Memory T cell responses are often required to resolve intracellular bacterial
infections, hence effective vaccines should have the ability to generate long-lasting,
memory T cell populations. Memory cells are divided into central memory (CM) and
effector memory (EM) cells based on their expression of cell surface receptors. More
specifically, although both types of memory cells are positive for the adhesion molecule
CD44, CM T cells are also positive for CD62L and the chemokine receptor CCR7, while
EM T cells lack both (Sallusto et al., 1999; Kaech et al., 2002; Esser; et al., 2003).
It has been previously shown that targeting iFt to FcR via intranasal
immunization with ICs generates protection against lethal F. tularensis challenge in an
IFN- dependent fashion, indicative of a T cell recall response (Rawool et al., 2008).
Having established that intranasal immunization with mAb-iFt ICs increases the number
of activated DCs in the lungs during F. tularensis LVS infection, and antigen
presentation by DCs can effectively program T lymphocytes to differentiate into memory
cells (Esser et al., 2003), an experiment was designed to determine the effect FcR
targeting on the generation of memory CD4+ T cells. For this purpose, C57BL/6 mice
were immunized with PBS, or iFt, F(ab’)2-iFt or mAb-iFt and boosted on day 21. On
day 35 post-immunization, the lungs and spleens of immunized mice were harvested and
the lymphocytes were stained with the relevant mAb followed by flow cytometric
analysis as described in the Materials and Methods. In accordance with previous studies,

41

EM CD4+ T cells were characterized as CD3+/CD4+/CD44high/CD62Llow/CCR7-, while
the

phenotype

of

CM

memory

CD4+

T

cells

was

CD3+/CD4+/CD44high/CD62Lhigh/CCR7+. Interestingly, regardless of the type of
immunization, there was no generation of EM CD4+ T cells in the spleen or lungs of
immunized mice (Fig. 10A). In fact, a similar population of CM T cells was present in all
three groups, regardless of the type of immunogen used (Fig. 10A). Most importantly
though, F. tularensis LVS infection of immunized mice generated a population of EM
CD4+ T cells both in the lungs and spleens of mice within two days post infection (Fig.
10B ). The levels of EM CD4+ T cells elicited during bacterial challenge were
significantly higher in the mAb-iFt immunized group compared to iFt (Fig. 10B). The
cells characterized as CM CD4+ T cells were also CCR7+ while the EM CD4 cells had
very low levels of CCR7 expression (data not shown). The enhancement of the effector
T cell population in the mAb-iFt IC immunized group indicated that targeting antigens to
FcR can drive the generation of effector memory immune responses both locally (lung)
and systemically (spleen) during bacterial infection. Mice immunized with F(ab’)2-iFt
ICs followed by F. tularensis LVS challenge, generated similar levels of EM CD4+ T
cells compared to the iFt immunized group, confirming that Fc receptor targeting of the
immunogen is essential for this observation (Fig. 10B-10C). Importantly, the EM CD4+
T cells generated following Fc receptor targeting of iFt were persistent for at least 25
days after F. tularensis LVS infection (Fig. 10B).
Interestingly, the population of central memory CD4+ T cells was negligible
within two days following F. tularensis LVS infection in all three groups of mice (Fig.
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10B).

The qualitative (Fig.10B) and quantitative (Fig.10C) enhanced generation of

effector versus central memory T cells observed in the mAb-iFt immunized group,
suggests that EM CD4+ T cells have a more pivotal role in mediating protection against
lethal F. tularensis LVS challenge over their CM counterparts.
Currently, the generation of effector vs central memory CD8+ T lymphocytes in
F. tularensis model is being evaluated as this subpopulation of T cells have also been
shown to play an important role in protection against this mucosal bacterial pathogen
(Conlan et al., 1994; Yee et al., 1996).
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Fig. 10 Enhanced generation of effector memory CD4+ T cells in the spleen and
lungs of mice immunized with mAb- iFt ICs, following F. tularensis LVS challenge
C57BL/6 mice (n=3 for each group) were immunized with PBS, iFt, mAb- iFt or F(ab’)2iFt and challenged as described in Fig. 7. On day 35 post-immunization or on day 2 postF. tularensis LVS challenge, the lungs and spleens of immunized mice were harvested
and the white blood cells were obtained and counted. Expression levels of
CD3+/CD4+/CD44+/CD62L+/CCR7+ T cells post-immunization (A) and post-infection
(B), as well as their absolute numbers (C) were analyzed by flow cytometry. The effector
memory cells (EM) are presented as CD44+ / CD62L- while the central memory cells
(CM) are presented as CD44+ / CD62L+. Results shown are mean ± SD from three
independent experiments determined by one-way ANOVA and Student’s t-test (* P-value
˂ 0.1; ** P-value ˂ 0.05).
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IL-12 is necessary for protection against lethal F. tularensis LVS challenge following
immunization with mAb-iFt ICs
The importance of T cells and IFN- in protection against F. tularensis LVS
infection following immunization with mAb-iFt ICs provides evidence for the generation
of a Th-1- like protective immune response. It is widely established that IL-12, secreted
mainly by innate immune cells, such as DCs and macrophages, drives the differentiation
of Th-1 effector T cells (Hsieh et al., 1993). Thus, it was hypothesized that the protective
immune responses elicited following targeting of iFt to FcR are dependent upon IL-12.
In order to confirm this hypothesis, IL-12p35-deficient mice, and their control
counterparts (C57BL/6), were immunized with PBS, iFt, or mAb-iFt, boosted on day 21,
and infected with a lethal dose of F. tularensis LVS on day 35 post-immunization. The
mice deficient for the p35 IL-12 subunit (as opposed to p40 deficient mice) have been
selected due to the role of the p35 gene in the development of Th-1 responses (Liu et al.,
2003). In addition, the p40 subunit is not unique to IL-12 as it is also shared by IL-23.
As anticipated, based on previous studies, 100% of the C57BL/6 mice that were
immunized with mAb-iFt ICs survived the F. tularensis LVS challenge while
immunization with iFt alone provided only 50% protection (Fig. 11A).

IL-12p35-

deficient mice though succumbed to infection within 13 days, regardless of the type of
immunization indicating the importance of IL-12 in protection generated by FcγR
targeting (Fig.11B). The role of IL-12 in protection against lethal F. tularensis challenge
is evident in both the iFt and mAb-iFt immunized IL-12p35-deficient mice as both
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groups completely succumbed to the infection. This indicates that targeting of the fixed
bacterial immunogen to FcγR on APCs drives the production of higher levels of IL-12
during F. tularensis LVS challenge compared to iFt alone pointing towards quantitative
versus qualitative difference between the two immunization approaches. In addition,
there was significantly more lung DCs producing IL-12 from mAb-iFt IC immunized
mice following F. tularensis LVS challenge, than from challenged mice immunized with
iFt alone. The numbers of lung DCs positive for IL-12 from challenged mice immunized
with the F(ab’)2-iFt ICs were also comparable to the iFt group, indicating that the
increase in IL-12 production from lung DCs is FcγR-targeting dependent (Fig. 11C).
Furthermore, culture of peritoneal cells (PECs) from mAb-iFt immunized and challenged
mice with live F. tularensis LVS, led to significantly higher levels of IL-12p70 secretion
as compared to PECs from challenged mice immunized with iFt alone (Fig. 11D). These
data, collectively, present for the first time the importance of IL-12 in generating
protective responses against F. tularensis LVS challenge when utilizing our FcγR
targeting vaccine model.
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Fig. 11 Targeting of iFt to FcγR provides protection against F. tularensis LVS
challenge in an IL-12-dependant fashion
C57BL/6 (A) or IL-12-deficient mice (B) (n=6 for each group) were immunized i.n. with
9
PBS, iFt (1x10 CFUs), or mAb- iFt, boosted on day 21 and challenged on day 35 with
20,000 CFUs of F. tularensis LVS. Survival was monitored for 25 days post-infection
and survival curves were generated using the Log-Rank (Mantel-Cox) test. The P- value
for iFt versus mAb- iFt in A (C57BL/6) was 0.041. There was no significant difference
between iFt and mAb- iFt immunized IL-12-deficient mice (B). C57BL/6 (C and D) mice
9
were immunized i.n. with PBS, iFt (1x10 CFUs), mAb- iFt, or F(ab’)2- iFt, boosted on
day 21 and challenged on day 35 with 20,000 CFUs of F. tularensis LVS. Two days postinfection lung DCs were obtained as previously described and stained intracellularly for
IL-12 (C). Peritoneal exudate cells (PECs) were also obtained from all groups and
3
cultured for 24 hours or 48 hours with F. tularensis LVS (1 x 10 CFUs /well).
Supernatants were collected at designated time points and the levels of IL-12p70 were
measured by CBA (D). Statistical analyses were carried out using the one-way ANOVA
(* P-value ˂ 0.1; ** P-value ˂ 0.05).
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IL-12 is required for the generation of effector memory CD4+ T cells upon
intranasal immunization with mAb-iFt IC and subsequent F. tularensis LVS
challenge
Having established that protection against F. tularensis LVS challenge via
intranasal immunization with mAb-iFt ICs is IL-12 dependent, the role of the latter in the
generation of effector memory CD4+ T cells following FcR targeting was also
examined. C57BL/6 mice were immunized i.n. with PBS, iFt, or mAb-iFt, boosted on
day 21, and challenged on day 35 with a lethal dose of F. tularensis LVS. Mice were
also injected i.p. with rat IgG2a anti-IL-12p35 or the isotype control on days 0, and 1
post-F. tularensis LVS infection. On day 2 after F. tularensis LVS challenge the levels
of effector memory CD4+ T cells in the lungs and spleens of immunized mice were
analyzed by flow cytometry. The data indicated that neutralization of IL-12 in vivo via
the administration of anti-IL-12 mAb significantly reduced the frequency and number of
effector memory CD4+ T cells both in the lungs and spleen of immunized mice (Fig. 12A
and 13A, respectively). In accordance with these results, immunization of IL-12-deficient
mice with iFt or mAb-iFt ICs, followed by lethal LVS infection, failed to enhance the
generation of effector memory CD4+ T cells in both the lungs and the spleens of
immunized mice (Fig. 12B and 13B). Altogether, these data suggest that the necessity of
IL-12 for protection against lethal F. tularensis LVS challenge is, in part, due to the
ability of IL-12 to generate EM CD4+ T cells, following targeting of bacterial
immunogens to FcγR.
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Fig. 12 Generation of effector memory CD4+ T cells following targeting of iFt to
FcγR, during F. tularensis LVS challenge, is IL-12-dependant
C57BL/6 (A) or IL-12-deficient mice (B) (n=4 for each group) were immunized and
challenged as described in Fig. 11. C57BL/6 mice were also injected i.p. with rat IgG2a
anti-IL-12 (500mg/dose), or the control isotype, on days -1, 0, and 1 post-LVS infection.
On day 2 after F. tularensis LVS challenge, the lungs and spleens of immunized C57BL/6
mice (A) and IL-12-deficient mice (B) were harvested and the white blood cells were
obtained and counted. Expression levels of CD3+/CD4+/CD44+/CD62L+/CCR7+ T cells in
the lungs and spleens of immunized C57BL/6 mice (A) and IL-12-deficient mice (B)
were obtained by flow cytometry. The effector memory cells are presented as CD44+ /
CD62L- while the central memory cells are presented as CD44+ / CD62L+. Results are
representative of three independent experiments.
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Fig. 13 Immunization of mice with mAb- iFt immune complexes increases the
absolute numbers of effector memory CD4+ T cells, during F.tularensis LVS
infection, in an IL-12-dependant fashion
Immunization and challenge studies were conducted in C57BL/6 (A) or IL-12-deficient
mice (B) (n=4 for each group) as in Fig. 11. On day 2 after F. tularensis LVS challenge,
the lungs and spleens of immunized mice were harvested and the lymphocytes were
obtained and counted. C57BL/6 mice were also injected i.p. with rat IgG2a anti-IL-12
(500mg/dose), or the control isotype, on days -1, 0, and 1 after LVS infection. Expression
levels of CD3+/CD4+/CD44+/CD62L+/CCR7+ T cells in the lungs and spleens of
immunized C57BL/6 mice (A) and IL-12-deficient mice (B) were obtained by flow
cytometry and their absolute numbers were calculated. Results shown are mean ± SD
from three independent experiments. Statistical analyses were carried out using the oneway ANOVA (* P-value ˂ 0.1; ** P-value ˂ 0.05).
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Enhanced generation of IFN- secreting CD4+ effector memory T cells during F.
tularensis LVS challenge in mice immunized i.n. with mAb-iFt ICs
The importance of IFN- in protection against F. tularensis LVS challenge, and
the enhanced generation of effector CD4+ memory T cells following mAb-iFt
immunization, led to hypothesis that the latter cell population is involved in the
production of IFN- during F. tularensis LVS infection. To test this, C57BL/6 mice were
immunized i.n. with PBS, iFt, or mAb-iFt, boosted on day 21, and challenged on day 35
with a lethal dose of F. tularensis LVS. Two days post-challenge, splenocytes from
immunized mice were obtained and cultured for 5 hours in the presence or absence of F.
tularensis LVS, while PMA and ionomycin were used as positive controls. Following
incubation, cells were collected and pooled from each group, stained for the extracellular
markers CD4/CD44/CD62L/CCR7 and intracellularly for IFN-. As depicted in Figure
14, there were significantly more F.tularensis-specific CD4+ splenocytes from mAb-iFt
immunized mice that secreted IFN- upon in vitro re-stimulation. The CD4+ / IFN-+
double positive cells also possessed the EM phenotype (CD44+/CD62Llow/CCR7-).
These observations indicate that the source of IFN-, essential for protection against F.
tularensis LVS challenge, is at least in part the effector memory CD4+ T cells generated
following i.n. immunization with mAb-iFt ICs. Surprisingly, the CD4-/IFN-γ+ population
observed were not CD8+ T lymphocytes (data not shown).
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Fig. 14 Increased generation of IFN-γ producing effector CD4+ T cells in mice
immunized with mAb- iFt IC compared to mice immunized with iFt alone
C57BL/6 (n=4 for each group) were immunized and challenged as described in Fig. 7. On
day 2 after F. tularensis LVS challenge, the spleens were harvested and splenocytes were
3
5
cultured for 5 hours with F. tularensis LVS (1 x 10 CFUs per 2 x 10 SPCs/well).
Following incubation cells from each group were pooled, counted, and stained
extracellularly for CD4, CD44, CD62L and CCR7 and intracellularly for IFN-γ. Analysis
(A) and enumeration (B) of IFN-γ+ effector CD4+ T cells were done by flow cytometry.
Data shown are mean ± SD from two independent experiments determined by Student’s ttest. The P- value for the iFt versus the mAb- iFt group in panel B was 0.03 (* P-value ˂
0.1; ** P-value ˂ 0.05).
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Discussion

Francisella tularensis is a Gram-negative intracellular bacterium that causes
tularemia, a disease that could potentially be fatal in humans and animals. It can be
transmitted through insect bites, infected carcasses, contaminated water, and inhalation of
contaminated air (Metzger et al., 2007). Because of its high infectivity the Centers for
Disease Control and Prevention designates F. tularensis as a Category A biological agent
(Rotz et al., 2002).

The search for a safe and effective vaccine against infectious

tularemia is still ongoing due to the lack of clear understanding of its pathogenesis. One
of the major questions is to understand pathobiology of the bacterium and to evaluate the
host’s immune responses in the early stages of infection.
The current study demonstrated for the first time that targeting of inactivated F.
tularensis (iFt) bacteria to Fcγ receptors via formation of immune complexes reverses the
potential detrimental effect of IL-10 during the early stages of F. tularensis infection.
Due to the lack of an identified F. tularensis protective antigen, the focus was on an
inactivated vaccine, which has been shown to protect against highly virulent SchuS4
organism in the highly stringent animal model C57BL/6 (Rawool et al., 2008).
Early control of bacterial infection depends on the secretion of pro-inflammatory
cytokines that regulate the activation of antigen presenting cells and the generation of a
protective Th-1-like response (Medzhitov & Janeway, 1997; Pashine et al., 2005;
Kalinski, 2012). One of the characteristics of F. tularensis infection is the lack of such
responses during early progression of infection. While some studies depict that this
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effect is due to the low endotoxicity of F. tularensis lipopolysaccharide, which is
structurally different from other Gram-negative bacteria (Ancuta et al., 1996; Barker et
al., 2006; Duenas et al., 2006; Hajjar et al., 2006), other studies show that the potential
up-regulation of anti-inflammatory cytokines is an important factor in the progression of
F. tularensis infection (Woolard et al., 2007; Metzger et al., 2013). The latter could
possibly be due to suppression of the early activation of inflammasome by F. tularensis,
one of the mechanisms that the bacteria utilizes to evade the early immune response
(Huang et al., 2010; Ulland et al., 2010; Dotson et al., 2013).
The anti-inflammatory cytokine IL-10 plays a major role in suppression of host
immune system by inhibiting the antigen presentation ability of macrophages and
dendritic cells mainly by down-regulating the expression of CD80, CD86 and MHC class
II molecules, as well as the production of pro-inflammatory cytokines (Pestka et al.,
2004).

The ability of IL-10 to suppress innate, inflammatory responses against

intracellular pathogens has been previously reported. For instance, lack of endogenous
IL-10 production led to a decrease in number of Trypanosoma cruzi parasites in the blood
of infected mice (Abrahamsohn & Coffman, 1996). Similarly, lack of IL-10 resulted in
higher resistance of mice to Listeria monocytogenes (Dai et al., 1997). In addition,
viruses have also evolved mechanisms to escape the immune response by altering the
Th1/Th2 balance. Thus, it has been shown that elevated levels of IL-10 correlated with
higher viral load in HIV infected individuals (Brockman et al., 2009).
IL-10 has also been identified as a key regulator of immune response to F.
tularensis infection (Metzger et al., 2013). In particular, IL-10 mediates suppression of
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IL-17, a cytokine that is essential in the initiation of a protective immune response to F.
tularensis infection (Leiby et al., 1992; Elkins et al., 2003; Duckett et al., 2005; Lin et al.,
2009).
It is well established that targeting of antigen to FcγRs using a receptor subclassspecific monoclonal antibodies increases the binding, internalization and processing of an
antigen by antigen presenting cells (APCs) in the absence of an adjuvant (Gosselin et al.,
1992). Furthermore, targeting of inactivated F. tularensis bacteria to FcγRs through
intranasal immunization of mice with mAb-iFt enhances immune response and protection
against F. tularensis infection possibly via FcγR dependent enhanced uptake of the
antigen by APCs and further presentation to T cells leading to enhanced T cell activation
(Rawool et al., 2008; Iglesias et al., 2012). The current study have showed that a
potential mechanism of protection in the F. tularensis model utilized, following FcγR
targeting of fixed bacteria, entails the generation of a Th-1 response during the early
phases of F. tularensis infection, by inhibiting the synthesis of the anti-inflammatory
cytokine IL-10.
Numerous studies have demonstrated that during F. tularensis infection the early
pro-inflammatory responses are significantly suppressed Bosio et al., 2007; Walters et al.,
2013), followed by overwhelming up-regulation after 48 hours of infection leading to a
severe sepsis (Mares et al., 2008; Sharma et al., 2009). The results of these current
experiments show that iFt targeting to FcγRs up-regulates pro-inflammatory responses at
early stages of F. tularensis infection both ex vivo and in vivo. Particularly, immunization
of C57BL/6 mice with mAb-iFt shifted the cytokine profile towards a pro-inflammatory
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Th-1 type in the lungs and peritoneum of immunized mice during LVS infection, which
was associated with reduction in bacterial load. Conversely, immunization with PBS and
the inactivated immunogen alone resulted in considerably lower amounts of Th1
cytokines and higher amounts of IL-10 synthesis accompanied by an increase in bacterial
burden in the lungs of infected mice. These observations indicate that immunization of
animals with mAb-iFt elicits a robust, pro-inflammatory immune response in the early
phases of F. tularensis infection by reversing the inhibitory effect of IL-10 both locally
and systemically.
The components of F. tularensis that contribute to the inhibition of proinflammatory responses are not completely understood yet.

However, it is well

established that F.tularensis LPS shows low endotoxic activity due to its structural
differences from other intracellular pathogens (Ancuta et al., 1996; Barker et al., 2006;
Duenas et al., 2006; Hajjar et al., 2006). These findings that F. tularensis LPS elicits
inefficient pro-inflammatory response and up-regulates IL-10 synthesis indicate that LPS
is partly responsible for the anti-inflammatory activities of F. tularensis LVS. The
importance of pro-inflammatory cytokines, in particular IFN-γ, in controlling the
intracellular infection has been described in previous reports. IFN-γ deficiency in mice
during Listeria monocytogenes infection compromised activation of macrophages
allowing bacteria to escape from phagolysome and further replicate within cytoplasm
(Dai et al., 1997). Similarly, lack of IFN-γ resulted in decreased survival of mice and
increase in bacterial burden during Legionella pneumophila infection (Shinozawa et al.,
2002). In addition, IFN-γ dependent activation of human monocyte-derived macrophages
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inhibited escape of F. tularensis into the cytoplasm, thus preventing bacterial replication
(Santic et al., 2005). In the current study it was observed that the increased IL-10
synthesis in the early stages of F. tularensis infection coincided with a decrease of the
pro-inflammatory cytokines IL-12p70 and TNF-α in the absence of endogenous IFN-γ.
Addition of exogenous IFN-γ to cultures of LPS-treated PECs, however, was able to
reverse this suppression. Likewise, an increase in the synthesis of IL-12p70 and TNF-α
was observed in IL-10 deficient mice after stimulation with F. tularensis LPS. Therefore,
these data demonstrate that early up-regulation of IL-10 is one of the means of Th-1
immune response suppression during early stages of F. tularensis infection, enabling the
bacteria to avoid classical anti-bacterial mechanisms.
The source of pro-inflammatory cytokines during infection is primarily the
professional antigen presenting cells, such as dendritic cells and macrophages. Proper
activation and differentiation of macrophages and dendritic cells is important for the
generation of robust, innate immune response against bacterial pathogens. Depending on
the extracellular cytokine background, the activated macrophages are divided into two
distinct groups, classically activated macrophages (AM1) associated with high levels of
pro-inflammatory

cytokines

and

alternatively

activated

macrophages

(AM2)

characterized by increased levels of anti-inflammatory cytokines, in particular IL-10
(Benoit et al., 2008). In fact, IL-10 and CCL17, both produced by AM2, are key players
in suppressing induction of AM1 cells (Katakura et al., 2004). Shirey et al. (2008)
demonstrated that F. tularensis LVS skews macrophage activation from anti-bacterial
AM1 phenotype towards AM2, which allows its survival and uncontrolled replication
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within host cells (Shirey et al., 2008). Based on these findings, the hypothesis was that
targeting of mAb-iFt may alter the macrophage phenotype from anti-inflammatory AM2
to pro-inflammatory AM1. The data showed that immunization of mice with mAb-iFt
resulted in higher frequency and number of AM1 cells compared to mice immunized with
iFt alone. In addition, a significantly lower number of AM2 cells in the lungs of mAb-iFt
immunized mice were observed relative to mice immunized with iFt alone. Interestingly,
immunization with PBS resulted in the highest frequency of AM2 cells, suggesting that
AM2 polarization in vivo may be an additional immune evasion strategy of F. tularensis,
especially at the early stages of infection.
Further, it was demonstrated that this vaccination strategy increases the frequency
and activation of DCs in the lungs of immunized mice during F. tularensis infection,
while it enhances the generation of effector memory CD4+ T cells, both locally (lung)
and systemically (spleen), in an IL-12-dependent fashion. This effector memory cell
population is believed to play an important role in the protection observed against F.
tularensis LVS challenge, partly via its increased ability to produce IFN-. Although the
antibodies tend to form bacterial aggregates, the findings of this study depend upon
specifically targeting antigens to FcγRs. In particular, it was observed that the
immunization with F(ab’2) mAb-iFt ICs failed to enhance recruitment and activation of
DCs in the lungs of immunized mice as well as to generate effector memory CD4+ T cells
during infection. These results are in agreement with previous reports where subdued
immune responses were observed when utilizing immune complexes lacking Fc domain
(Rawool et al., 2008; Iglesias et al., 2012).
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Modulating DCs, one of the most important professional APCs of the immune
system, presents an attractive target for vaccine design. Indeed, DCs migrating from the
periphery to secondary and tertiary lymphoid organs, loaded with exogenous antigens and
activated by “danger signals”, identify naïve T cells and induce their proliferation and
differentiation to effector and memory phenotypes. Indeed, the superior capacity of DCs
to activate naïve T cells following nasal and oral immunizations has been determined in
several studies (Vermaelen et al., 2001; Anjuere et al., 2004; Chirdo et al., 2005;
Wikstrom et al., 2006; Jaensson et al., 2008). In the current study, targeting iFt to FcR
via intranasal immunization of mice with mAb-iFt ICs increased the overall white blood
cell cellularity of immunized mice during F. tularensis LVS infection compared to mice
immunized with iFt alone. Most importantly, the frequency and activation status of lung
DCs was also significantly increased post-challenge. Mice immunized with F(ab’)2 – iFt
ICs failed to recruit and increase the activation of DCs in the lungs, indicating that this
effect is dependent upon targeting of the immunogen to FcγRs. However, it is currently
unclear whether expression of FcγR is required for DCs recruitment and activation.
Nevertheless, the enhanced generation of activated DCs in the lungs of mice immunized
with ICs provides evidence of enhanced mucosal immunity.
Although it has been previously established that FcγR targeting of a fixed
bacterial immunogen (iFt) in vitro leads to DC activation (Iglesias et al., 2012), the exact
mechanism that leads to their in vivo maturation and potential recruitment in the lungs
remains unclear. At different developmental stages and at various anatomical sites DCs
may express various chemokine receptors including: CCR1, CCR2, CCR4, CCR5,
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CCR6, CCR7, CXCR1, and CXCR4 (Dieu et al., 1998; Cyster, 1999; Sallusto et al.,
1999(a); Sallusto et al., 1999(b); Sallusto et., 1999(c)). These findings suggest that
chemokines and chemokine receptor expression levels may regulate DC trafficking.
Indeed, in various infection models, including Mycobacterium bovis, Schistosoma
mansoni, and Cryptococcus neoformans, expression of CCR2 in mice was necessary for
DC recruitment and activation (Chiu et al., 2004; Osterholzer et al., 2008). Similarly, in
two F. tularensis studies using F. tularensis LVS, CCR7+ DCs were found to be recruited
in areas of high CCL19 and CCL21 chemokine concentrations (Bar-Haim et al., 2008;
Chiavolini et al., 2010). Whether the levels of these chemokines are increased
significantly in the lungs of IC immunized mice over mice administered with iFt alone,
essentially recruiting mature DCs from peripheral sites remains to be addressed.
Chemokine expression also plays a role in the recruitment of CD4+ T cells at the
sites of infection where they are exposed to concentrated amounts of polarizing
cytokines, such as IL-12, secreted by the activated DCs (Osterholzer et al., 2008). In the
current study, lung DCs from mAb-iFt IC immunized mice had an increased ability to
secrete IL-12 upon re-stimulation in vitro compared to mice immunized with the
untargeted iFt. The activated DCs would efficiently present F. tularensis antigens to
CD4+ T cells polarizing them towards a Th-1 phenotype via secretion of IL-12 and
driving their differentiation towards a protective effector memory phenotype.
Furthermore, the observation that PECs showed increased secretion of IL-12 upon restimulation in vitro is of great interest as it depicts the ability of this vaccine strategy to
elicit both mucosal and systemic protective immune responses. Indeed, immunization of
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mice with mAb-iFt ICs increased the expression of MHC class II and co-stimulatory
molecules (B7.1 and B7.2) on the surface of lung DCs in vivo, hence facilitating a more
robust antigen presentation to T lymphocytes and subsequent generation of memory. It is
believed the activation of lung DCs is a direct effect of FcγR targeting and is not aided by
the LPS present in the bacterial cell wall.

This is evident due to the significant

differences in DCs maturation between the iFt and mAb-iFt immunized mice.

In

addition, F. tularensis LPS is structurally different from other enteric LPS and has
reduced stimulatory effect on APCs (Ancuta et al. 1996; Duenas et al., 2006).
Although it is clear that memory T cells can be distinguished into central and
effector subtypes, their relevance during recall responses has been controversial. Central
memory (CM) T cells usually reside in the secondary lymphoid tissues due to their high
expression of CD62L and CCR7. Effector memory (EM) T cells on the other hand, have
a greater capacity to migrate to inflamed tissues, partly due to increased expression of
chemokine receptors, such as CCR2 and CCR5 (Gunn et al., 1998; Sallusto et al., 1999
(a); Campbell & Butcher, 2000; Kaech et al., 2002; Esser et al., 2003; McKinstry et al.,
2010). Generation of memory lymphocytes is often used to assess vaccination strategies,
especially against intracellular pathogens. It has been previously shown that
immunization with mAb-iFt immune complexes provides protection against F. tularensis
infection 30 days post-immunization, indicating that targeting of bacterial antigens to
FcγR results in the generation of protective memory lymphocytes (Rawool et al., 2008).
The lack of an increased CM T cell population though following FcR targeting, was
surprising. Perhaps the significant enhancement of EM T cells during F. tularensis LVS
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infection is of vital importance for the protection observed in animal model used in this
study. Indeed, it has been shown that at early stages after bacterial infection, effector
cells dominate the memory pool and provide potent protective immunity (Roberts et al.,
2005).
The origin of the EM CD4+ T cells in the current study remains unclear. One
possibility is that these cells were generated in the secondary lymphoid organs, such as
spleen and lymph nodes, and homed to the lungs early, after F. tularensis LVS challenge,
possibly in a chemokine-dependent manner. Alternatively, the EM T cells may have
been generated locally, from the central memory pool. Indeed, in an elegant study from
Blander et al., (2003), use of a transgenic T cell line showed that a significant percentage
of CM T lymphocytes can acquire effector functions upon re-stimulation (Blander et al.,
2003). Although the levels of CM T cells in the lungs and spleens of IC immunized mice
were not different from the levels observed in mice immunized with iFt alone, it is
speculated that the differences at the post-immunization stage are qualitative. It is likely
that the enhanced activation status of DCs enable them to generate CM T cells that are
more effectively programmed to switch to an effector memory phenotype during
infection, both in the mucosa and systemically. Therefore, it is clear that the ability of
vaccines to induce EM T cells is a requirement for protection. In addition, generation of
EM cells in the secondary lymphoid organs requires prolonged and systemic exposure of
the immunogen which often poses a challenge, especially for non-replicative vaccine
vectors. It is possible that targeting iFt to FcR aids the widespread distribution of

62

antigen, increasing the number of antigen encounters by naïve T cells and thus
circumventing this problem.
Currently it is not certain whether the EM CD4+ T cells are independently capable
to provide protection against pulmonary infection with F. tularensis. Previous studies
have implicated both CD4+ and CD8+ T cell subtypes in protection against this mucosal
pathogen as neutralization of either CD4+ or CD8+ T cells in vivo was not detrimental to
the host (Conlan et al., 1994; Yee et al., 1996). One can assume that protection mediated
by CD4+ T cells is mainly IFN-γ dependent while the cytotoxic effects of CD8+ T
lymphocytes will be important in clearing the infection. The independent protective role
of CD4+ T cells in the model used is currently under investigation via adoptive transfer
experiments, while the effect of mAb-iFt IC immunization on the generation of CD8+
memory T lymphocytes is also currently being studied.
Another aspect to be considered in vaccine design is the maintenance of effector
memory cells. Apart from persistence of the immunogen, the cytokine milieu may
mediate the long-term survival of these memory cells. More specifically, Esser et al.,
(2003), suggested that IL-12 may be a candidate factor to maintain CD4+ memory cells
(Esser et al., 2003). In addition, IL-12 has been shown to enhance the potency and
increase the durability of a leishmanial protein vaccine in mice (Gurunathan et al., 1998).
In this study, IL-12 was necessary in protection against lethal F. tularensis LVS
challenge as well as for generating EM CD4+ T cells.

This is in accordance with

previous studies showing that both subunits of IL-12 (p35 and p40) are essential in
resolving pulmonary F. tularensis infection while the administration of recombinant IL-
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12 i.n. facilitates bacterial clearance from the lungs of infected mice (Elkins et al., 2002;
Pammit et al., 2004; Duckett et al., 2005). Therefore, it is likely that targeting iFt to
FcR on DCs (and potentially macrophages as well) increases the levels of IL-12 in vivo
which drives EM T cell differentiation that is long-lived and displays Th-1-phenotype
characteristics. In the current model, EM CD4+ T cells from IC immunized mice had
higher frequency as well as increased ability to secrete IFN- compared to cells obtained
from mice immunized with iFt alone, upon in vitro re-stimulation with F. tularensis LVS.
It is believed that the CD4+ EM T-lymphocytes generated in this vaccine platform are
also long lived as significant populations of these cells were still detectable 25 days post
F. tularensis LVS challenge. The presence of IFN-γ in the memory CD4+ T lymphocytes
following in vitro re-stimulation with F. tularensis LVS indicates specificity against F.
tularensis.

Enhanced production of IFN-γ in vivo can activate macrophages thus

facilitating bacterial clearance while driving the switch towards Th-1 like antibody
isotypes, such as IgG2a or IgG2c. Indeed, a Th-1 like antibody response against F.
tularensis has been previously shown following targeting of bacterial antigens to FcγR
(Rawool et al., 2008). Hence, these observations indicate that FcR targeting mediates
Th-1 polarization of EM T lymphocytes through IL-12 secretion, while it generates a
greater frequency of antigen-specific memory T cells. The lack of protection against
lethal F. tularensis LVS challenge following immunization of IFN- deficient mice with
mAb-iFt IC (Rawool et al., 2008), leads to conclusion that the ability of EM T cells to
produce IFN- may be indispensable for protection in this immunization model.
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The specific F. tularensis responses observed in this study also revealed a CD4cell population that expressed IFN-γ during re-stimulation with F. tularensis LVS in
vitro. This population had higher frequency in the mAb-iFt immunized mice, suggesting
a memory recall response, but surprisingly these cells were not CD8+ T lymphocytes
either.

Nevertheless, the potential CD8-mediated mechanisms are currently under

investigation.
It has been previously shown that targeting of the fixed immunogen, iFt, to FcγR
provided 20-50% protection in C57BL/6 mice against the more lethal F. tularensis strain,
SchuS4 (Rawool et al., 2008). It would be of interest to investigate whether SchuS4
infection generates similar cellular immune responses, although the partial protection
observed against this strain would account for more subtle differences among the
immunized groups. For this reason, the current study focused primarily on F. tularensis
LVS model, although the analysis of cell mediated mechanisms involved in SchuS4
protection is in the future scope of studies.
In summary, the present work advances our understanding of the in vivo
protective mechanisms involved following FcγR targeting of a fixed bacterial
immunogen.

For the first time it is demonstrated that targeting of inactivated F.

tularensis bacteria to FcγRs reverses the potential detrimental effect of IL-10 during the
early stages of F. tularensis infection. The anti-inflammatory cytokine IL-10 secreted by
F. tularensis infected murine macrophages promotes the bacterial survival and replication
by suppressing the synthesis of pro-inflammatory cytokines TNF-α, IL-12, IL-6 and IFNγ. The immunization of mice with mAb-iFt triggers activation of macrophages, shifts the
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cytokine profile from anti-inflammatory towards pro-inflammatory and alters
macrophage activation state from alternatively activated to classically activated
macrophages. Intranasal immunization of mice with mAb-iFt IC increases the frequency
of activated DCs as well as the generation of F. tularensis-specific, IFN- secreting, EM
CD4+ T cells. Generation and maintenance of the EM T cell population is dependent
upon IL-12 that is partially produced by activated lung DCs, but also systemically by
other professional APCs. It is thought that the enhanced ability of the EM T cells to
secrete IFN- is necessary for protection against F. tularensis challenge.
These findings support the hypothesis that targeting bacterial immunogens to
FcγRs on antigen presenting cells is an effective way to enhance innate immunity against
intracellular pathogens during the early stages of infection. In addition, this is the first
study that implicates FcR in modulating DC and T cell responses in an infectious model
in vivo, essentially bridging the innate and adaptive branch of the immune system. The
enhanced cellular immune responses in the lungs and spleen of immunized mice observed
in this model provide evidence for the generation of pathogen-specific mucosal and
systemic immunity. Additional studies using the virulent type A F. tularensis SchuS4
strain will enhance our understanding of the pathogenesis and evasion mechanisms of F.
tularensis.

This targeting approach is highly applicable and promising as it fills a

significant gap left by the paucity of FDA approved adjuvants and the lack of effective
vaccines against mucosal pathogens.
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